| 标题 |
Effect of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Robert R Henry; A Michael Lincoff; Sunder Mudaliar; Michael Rabbia; Cathy Chognot; et al 出版日期:2009-07-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)